Medication info
Fosaronin Tablet 70 mg (Sodium Alendronate Hydrate)

Fosaronin Tablet 70 mg (Sodium Alendronate Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
White oval tablets
Packaging
4 tablets/PTP - 4 tablets/PTP
Approval status
Active

MFDS item code 200605491 · Notified 2006.06.16 · Insurance code 665000690

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take alendronic acid 70 mg once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medications may reduce absorption of this drug (see Drug Interactions). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce absorption of the drug in the body and diminish its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the drug reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this drug at bedtime or before getting up. Failure to follow these administration instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. ○ If you forget to take a dose on the scheduled day, take 70 mg the following morning, resume taking it on the originally scheduled day, and then continue regularly once weekly. However, do not take 2 tablets on the same day.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women and men. Osteoporosis is a condition that weakens bones, increasing the risk of fractures, and this medication helps to increase bone density and reduce the risk of fractures. Therefore, it is effective in maintaining bone health and preventing fractures.

How to take

Adult dose

○ Take alendronic acid 70 mg once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medications may reduce absorption of this drug (see Drug Interactions). Consuming food within 30 minutes after taking this drug, or at the same time, may reduce absorption of the drug in the body and diminish its effect. Take this drug as soon as you get up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the drug reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this drug at bedtime or before getting up. Failure to follow these administration instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. ○ If you forget to take a dose on the scheduled day, take 70 mg the following morning, resume taking it on the originally scheduled day, and then continue regularly once weekly. However, do not take 2 tablets on the same day.

Precautions

This medication can irritate the stomach and esophagus, so individuals with gastrointestinal conditions such as esophagitis or ulcers should be particularly cautious. Take this medication with a sufficient amount of water and avoid lying down for at least 30 minutes after taking it to minimize esophageal irritation. If difficulty swallowing, chest pain, or heartburn occurs, stop taking the medication immediately and consult a doctor. This medication is not to be administered to certain patients, such as those with esophageal stricture, severe renal impairment, pregnant or breastfeeding women. Additionally, it is advisable not to use it in cases of calcium deficiency or specific genetic conditions. While on this medication, it is important to maintain adequate intake of calcium and vitamin D, and supplements should be taken if necessary. This medication may cause musculoskeletal pain or gastrointestinal symptoms (abdominal pain, nausea, indigestion, etc.), so if abnormal symptoms persist, consult with a doctor. Patients undergoing dental treatment should consult their doctor before and after treatment due to the risk of osteonecrosis of the jaw. This medication may interact with other medications, so especially calcium supplements or antacids should be taken at least 30 minutes apart. Pregnant women or those who may become pregnant should not take this medication, and it is also advisable to avoid it while breastfeeding. Safety for children and adolescents under 18 has not been established, so use should be avoided. Elderly patients can take this medication, but caution should be exercised considering sensitivity differences with age. In case of overdose, gastrointestinal irritation and hypocalcemia may occur, and immediate medical attention should be sought, avoiding induced vomiting. This medication should be kept out of the reach of children, and transferring it to other containers should be avoided.

Side effects

Upper gastrointestinal mucosal irritation, bleeding, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, gastric ulcer, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbances, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oral pharyngeal ulcer, localized osteonecrosis of the jaw, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also recommended to store it at a temperature between 15°C and 30°C, avoiding extreme heat or cold.

Appearance and packaging

Appearance

White oval tablets

Package unit

4 tablets/PTP - 4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.